Home NDC 0172-5240 Anagrelide Hydrochloride
Product NDC 0172-5240
11-digit product format 001725240
Labeler code 0172
Product ID 0172-5240_fc800314-47d7-41ca-af8a-9222fbf5631c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Anagrelide Hydrochloride
Dosage form CAPSULE
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA076468
Marketing category ANDA
Marketing start 2005-04-18
Marketing end 0000-00-00
Substance ANAGRELIDE HYDROCHLORIDE
Active strength 1 mg/1
Pharmacologic classes Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product 0172-5240 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0172-5240 0172-5240-60 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076468-001 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 A076468-002 ANAGRELIDE HYDROCHLORIDE ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076468-001 ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB 2005-04-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A076468-002 ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL AB RS 2005-04-18 74a2ff9319b5…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 86 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ANAGRELIDE HYDROCHLORIDE ACTIVE INGREDIENT VNS4435G39 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 ANAGRELIDE ACTIVE MOIETY K9X45X0051 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 ANHYDROUS LACTOSE INACTIVE INGREDIENT 3SY5LH9PMK ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 GELATIN INACTIVE INGREDIENT 2G86QN327L ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 INDIGOTINDISULFONATE SODIUM INACTIVE INGREDIENT D3741U8K7L ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 POVIDONE K30 INACTIVE INGREDIENT U725QWY32X ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 SHELLAC INACTIVE INGREDIENT 46N107B71O ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ANAGRELIDE HYDROCHLORIDE CAPSULE [IVAX PHARMACEUTICALS, INC.] 15 Anagrelide Hydrochloride ACTIVE INGREDIENT VNS4435G39 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 Anagrelide ACTIVE MOIETY K9X45X0051 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 ANHYDROUS LACTOSE INACTIVE INGREDIENT 3SY5LH9PMK ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 GELATIN INACTIVE INGREDIENT 2G86QN327L ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 POVIDONE INACTIVE INGREDIENT FZ989GH94E ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ANAGRELIDE HYDROCHLORIDE CAPSULE [PHYSICIANS TOTAL CARE, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0172-5240 ANAGRELIDE HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA, INC.] 26 Legacy NDC 20250529_6727d5d4-e8ec-4a85-bc82-ec70b641eecf.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0172-5240-60 00172524060 100 CAPSULE in 1 BOTTLE (0172-5240-60) 100 capsule 2005-04-18 0000-00-00 No No Current